SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities
SEC Accession No. 0001005794-05-000586
Filing Date
2005-07-06
Accepted
2005-07-06 13:32:43
Documents
1
Period of Report
2005-06-27
Filing Date Changed
2005-07-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2113
  Complete submission text file 0001005794-05-000586.txt   3868
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Issuer) CIK: 0001047699 (see all company filings)

IRS No.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 501 FIFTH STREET BRISTOL TN 37620
Business Address (423)989-8000
Squicciarino Joseph (Reporting) CIK: 0001332129 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15875 | Film No.: 05939866